BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zinellu A, Zinellu E, Sotgiu E, Fois AG, Paliogiannis P, Scano V, Piras B, Sotgia S, Mangoni AA, Carru C, Pirina P. Systemic transsulfuration pathway thiol concentrations in chronic obstructive pulmonary disease patients. Eur J Clin Invest 2020;:e13267. [PMID: 32378181 DOI: 10.1111/eci.13267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Jiang S, Chen Y. The role of sulfur compounds in chronic obstructive pulmonary disease. Front Mol Biosci 2022;9:928287. [DOI: 10.3389/fmolb.2022.928287] [Reference Citation Analysis]
2 Krämer J, Kang R, Grimm LM, De Cola L, Picchetti P, Biedermann F. Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids. Chem Rev 2022. [PMID: 34995461 DOI: 10.1021/acs.chemrev.1c00746] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 27.0] [Reference Citation Analysis]
3 Turell L, Möller MN, Orrico F, Randall LM, Steglich M, Villar S, Denicola A, Thomson L. Thiols in blood. Redox Chemistry and Biology of Thiols 2022. [DOI: 10.1016/b978-0-323-90219-9.00025-x] [Reference Citation Analysis]
4 Taniguchi A, Tsuge M, Miyahara N, Tsukahara H. Reactive Oxygen Species and Antioxidative Defense in Chronic Obstructive Pulmonary Disease. Antioxidants (Basel) 2021;10:1537. [PMID: 34679673 DOI: 10.3390/antiox10101537] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
5 Marszalek-grabska M, Walczak K, Gawel K, Wicha-komsta K, Wnorowska S, Wnorowski A, Turski WA. Kynurenine emerges from the shadows – Current knowledge on its fate and function. Pharmacology & Therapeutics 2021;225:107845. [DOI: 10.1016/j.pharmthera.2021.107845] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
6 Sharma A, Tewari D, Nabavi SF, Nabavi SM, Habtemariam S. Reactive oxygen species modulators in pulmonary medicine. Curr Opin Pharmacol 2021;57:157-64. [PMID: 33743400 DOI: 10.1016/j.coph.2021.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Sotgia S, Fois AG, Paliogiannis P, Carru C, Mangoni AA, Zinellu A. Methodological Fallacies in the Determination of Serum/Plasma Glutathione Limit Its Translational Potential in Chronic Obstructive Pulmonary Disease. Molecules 2021;26:1572. [PMID: 33809301 DOI: 10.3390/molecules26061572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sotgia S, Paliogiannis P, Sotgiu E, Mellino S, Zinellu E, Fois AG, Pirina P, Carru C, Mangoni AA, Zinellu A. Systematic Review and Meta-Analysis of the Blood Glutathione Redox State in Chronic Obstructive Pulmonary Disease. Antioxidants (Basel) 2020;9:E1146. [PMID: 33218130 DOI: 10.3390/antiox9111146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
9 Silvagno F, Vernone A, Pescarmona GP. The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19. Antioxidants (Basel). 2020;9. [PMID: 32708578 DOI: 10.3390/antiox9070624] [Cited by in Crossref: 79] [Cited by in F6Publishing: 90] [Article Influence: 26.3] [Reference Citation Analysis]